| INTRODUCTION
Brugada syndrome is characterized by a type 1 coved-pattern electrocardiogram (ECG) in the right precordial leads in patients without apparent structural heart abnormalities. The disease increases the risk of ventricular arrhythmias and sudden cardiac death (SCD) (Brugada & Brugada, 1992) . However, risk stratification of Brugada syndrome remains unclear leading to a clinical challenge (Adler et al., 2016) . A history of cardiac arrest is a strong predictor of recurrent ventricular fibrillation (VF) up to 35%-48% at 4-10 years (Probst et al., 2010; Sacher et al., 2013) . Malignant syncope is considered as a moderate predictor of spontaneous VF (Probst et al., 2010) , whereas familial sudden cardiac death and the presence of a SCN5A mutation is less well-defined prognostic value (Adler et al., 2016) . For the ECG risk stratification, the presence of spontaneous type I ECG increases the risk for VF in all previous multivariate analysis studies (Delise et al., 2011; Priori et al., 2012; Probst et al., 2010) . Fragmented QRS (fQRS) has been reported as potential noninvasive tool for risk stratification in various cardiac conditions (Das & Zipes, 2009 ). In Brugada syndrome, the presence of fQRS correlates with increased risk in most of the studies (de Asmundis et al., 2017; Maury et al., 2013; Morita et al., 2008 Morita et al., , 2017 Priori et al., 2012; Take et al., 2012; Tokioka et al., 2014) . However, several studies did not show significant correlation (Conte et al., 2016; Sakamoto et al., 2016) thus the role of fQRS has been controversial (Adler et al., 2016) . We performed a meta-analysis to assess the predictive value of fQRS in precordial leads (V 1 -V 3 ) for the development of major arrhythmic events (MAE) in Brugada syndrome patient.
| METHODS

| Search strategy
Two investigators (NP and NL) independently searched for published studies indexed in MEDLINE and EMBASE databases from inception to June 2017 using a search strategy (Figure 1 ) that included the terms for "fragmented QRS," "QRS fragmentation," and "Brugada."
Only English language publications were included. A manual search for additional pertinent studies and review articles using references from retrieved articles was also completed.
| Inclusion criteria
The eligibility criteria included the following:
1. Cohort study (prospective or retrospective) reporting incident of major arrhythmic events (MAE) including VF, sustained ventricular tachycardia (sVT), sudden cardiac arrest, or sudden cardiac death, in Brugada syndrome patient with and without fQRS.
2.
Relative risk, hazard ratio, odds ratio, incidence ratio, or standardized incidence ratio with 95% confidence intervals or sufficient raw data for the calculation were provided.
3. Brugada syndrome participants without fQRS were used as controls.
Study eligibility was independently determined by two investigators (NK and PC) and differences were resolved by mutual consensus. Newcastle-Ottawa quality assessment scale was used to evaluate each study in three domains: recruitment and selection of the participants, similarity and comparability between the groups, and ascertainment of the outcome of interest among cohort studies (Stang, 2010) .
| Data extraction
A standardized data collection form was used to obtain the following information from each study: title of study, name of first author, year of study, year of publication, country of origin, number of participants, demographic data of participants, method used to identify cases and controls, method used to diagnose the outcomes of interest (fQRS and major arrhythmic events), and average duration of follow-up with confounders that were adjusted and adjusted effect estimates with 95% confidence intervals (CI) and covariates that were adjusted in the multivariable analysis.
To ensure accuracy, all investigators independently performed this data extraction process. Any data discrepancy was resolved by referring back to the original articles.
| Statistical analysis
We performed a meta-analysis of the included cohort studies using a random-effects model. The extracted studies were excluded from the analysis if they did not present an outcome in each intervention group or did not have enough information required for continuous data comparison. We pooled the point estimates from each study using the generic inverse-variance method of DerSimonian and Laird (1986) .
The heterogeneity of effect size estimates across these studies was quantified using the I 2 statistic and Q statistic. For the Q statistic, substantial heterogeneity was defined as p < .10. The I 2 statistic ranges in value from 0% to 100% (I 2 < 25%, low heterogeneity; I 2 = 25%-50%, moderate heterogeneity; and I 2 > 50%, substantial heterogeneity) (Higgins, Thompson, Deeks, & Altman, 2003) . A sensitivity analysis was performed to assess the influence of the individual studies on the overall results by omitting one study at a time. Publication bias was assessed using funnel plot and Egger's regression test (Sterne & Egger, 2001 ) (p < .05 was considered significant). All data analyses were performed using the Stata SE 14.1 software from StataCorp LP.
| Sensitivity analysis
We used a sequential exclusion strategy, as described by Patsopoulos and colleagues, to examine whether overall estimates were influenced by the substantial heterogeneity observed (Patsopoulos, Evangelou, & Ioannidis, 2008) . We sequentially and cumulatively excluded studies that accounted for the largest share of heterogeneity until I 2 was less than 50%. We then examined whether relative risk estimates were consistent. In accordance with Cochrane, evidence of publication bias was examined through funnel plots if there were more than 10 available studies. Funnel plot asymmetry was further confirmed with Egger's test. If asymmetry was present, we used the trim-and-fill method to adjust for publication bias. Potential bias from clinical characteristics were analyzed with subgroup analysis and were compared with meta-regression among European versus Japanese descendants, case-control versus cohort study design, and univariate versus multivariate analysis.
| RESULTS
| Description of included studies
Our search strategy yielded 24 potentially relevant articles (10 articles from EMBASE and 14 articles from MEDLINE). After exclusion of 8 duplicated articles, 16 articles underwent title and abstract review.
Two were excluded at this stage since they were not cohort studies, leaving 14 articles for full-length article review. Five studies were excluded: 1 abstract presentation, 1 potential duplicated studied population, 2 conducted in non-Brugada syndrome patients, 1 study of paced fQRS. Therefore, four retrospective and five prospective cohort studies with 550 fQRS and 1,810 non-fQRS Brugada syndrome pateints were included in this meta-analysis. The clinical characteristics are described in Table 1 .
| Quality assessment of included studies
The Newcastle-Ottawa scale (zero to nine) was used to evaluate included studies on three domains: selection, comparability, and outcomes. Higher scores represent higher study quality. The score of each study ranged from seven to nine which reflected the high quality of included studies. Intrastudy risks of bias including study F I G U R E 1 Search methodology and selection process
Potentially relevant articles identified from search of MEDLINE (n = 14) and EMBASE database (n = 10) and screened for retrieval
Title and abstract review of potentially relevant articles (n = 16) 2 article were excluded at this stage because of they were not cohort study Exclusion of 8 duplications 14 articles underwent full-length article review 5 articles were excluded at this stage as they were -1 study of paced fragmented QRS -1 abstract presentation -2 conducted in non-Brugada syndrome -1 potential duplicated population 9 articles underwent meta-analysis population definition, outcome definition, independent assessment of the outcome, follow-up duration, selective loss during follow-up, and identified limitation, were evaluated for each included study and no intrastudy risk of bias was identified.
| Meta-analysis results
Nine studies (550 fQRS and 1,810 non-fQRS) were included. Every study revealed an increased risk of MAE (VF, sVT, SCA, or SCD) in Brugada syndrome patients with seven meeting statistical significance (de Asmundis et al., 2017; Maury et al., 2013; Morita et al., 2008 Morita et al., , 2017 Priori et al., 2012; Take et al., 2012; Tokioka et al., 2014) . However, two studies did not show significant association 
| DISCUSSION
Brugada syndrome is an inherited arrhythmic heart disease which increases the risk of ventricular arrhythmias and SCD (Brugada & Brugada, 1992) . Recommended prevention strategies include exercise restriction, avoidance of excessive alcohol intake, anti-arrhythmic drugs, and implantable cardioverter defibrillator (ICD) (Priori et al., 2015) . Identifying those who would benefit from ICD is challenging but an essential part of clinical decision making. Since there is no randomized control trials or strong evidence that can be used to help decide on ICD implantation in Brugada syndrome patients, recommendations are based on cohort studies which provide relationship between clinical characteristics and prognostic outcomes.
A history of cardiac arrest (Probst et al., 2010; Sacher et al., 2013) , spontaneous type I ECG (Delise et al., 2011; Priori et al., 2012; Probst et al., 2010) , and malignant syncope (Probst et al., 2010) noninvasive tool for risk stratification in Brugada syndrome (Morita et al., 2008) . Initially, fQRS was reported to be correlated with myocardial scar and prognosis of old myocardial infarction (Das et al., 2008) .
The prognostic value of fQRS was then broadened to prediction of MAE and SCD in ischemic heart disease, nonischemic cardiomyopathy, and various heart disease patients (Das & Zipes, 2009; Das et al., 2008 Das et al., , 2010 .
In patients with Brugada syndrome, fQRS was reported to be appear in the right precordial leads and was correlated with MAE in symptomatic patients (Morita et al., 2008) . A prospective cohort study reported by Priori et al. showed that fQRS was a potential predictor of MAE in Brugada syndrome patients even without a previous history of cardiac arrest (Priori et al., 2012) . The presence of fQRS correlates with increased risk in most of the studies (de Asmundis et al., 2017; Maury et al., 2013; Morita et al., 2008 Morita et al., , 2017 Priori et al., 2012; Take et al., 2012; Tokioka et al., 2014) . However, the role of fQRS has been controversial (Adler et al., 2016) . Because of controversial results from previous studies, the prognostic value of fQRS in predicting MAE in Brugada syndrome had come into question (Adler et al., 2016) .
In the present study, we evaluated the fQRS in patients with BrS by systemic review and meta-analysis. To our knowledge, our study is the first meta-analysis to assess the predictive value of fQRS in precordial leads (V 1 -V 3 ) for the development of MAE in Brugada 
| LIMITATION
Our study is not without limitations. We limited fQRS to precordial leads V 1 -V 3 . There was no available reported data to examine fQRS in nonprecordial leads as a prognostic value of MAE and SCD. Different study populations and designs were included and thus might introduce potential sources of heterogeneity. However, we found no difference among exploratory subgroup analysis in European versus Japanese descendants, case-control versus cohort study design, and univariate versus multivariate analysis. We also did not demonstrate independent predictors of SCD in Brugada syndrome such as age, gender, diabetes, and hypertension because of insufficient data from included studies to perform meta-analysis in these subgroups. These factors might introduce potential sources of heterogeneity as well. Some heterogeneity exists among studies. Nonetheless, we used sensitivity analysis methods in the random-effects model and found no difference of the imputed risk ratio and its 95% confidence interval.
| CONCLUSION
In conclusion, our meta-analysis demonstrated that fQRS in precordial leads is a valuable predictor of MAE and SCD in Brugada syndrome patients. Fragmented QRS could be considered as a possible important factor for ICD implantation in Brugada syndrome patients. Further study is needed to establish its potential role in identifying the Brugada syndrome patients at highest risk of SCD.
